302 related articles for article (PubMed ID: 35052495)
21. Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases.
Wu P; Zuo X; Deng H; Liu X; Liu L; Ji A
Brain Res Bull; 2013 Aug; 97():69-80. PubMed ID: 23756188
[TBL] [Abstract][Full Text] [Related]
22. Long Noncoding RNA MANTIS Facilitates Endothelial Angiogenic Function.
Leisegang MS; Fork C; Josipovic I; Richter FM; Preussner J; Hu J; Miller MJ; Epah J; Hofmann P; Günther S; Moll F; Valasarajan C; Heidler J; Ponomareva Y; Freiman TM; Maegdefessel L; Plate KH; Mittelbronn M; Uchida S; Künne C; Stellos K; Schermuly RT; Weissmann N; Devraj K; Wittig I; Boon RA; Dimmeler S; Pullamsetti SS; Looso M; Miller FJ; Brandes RP
Circulation; 2017 Jul; 136(1):65-79. PubMed ID: 28351900
[TBL] [Abstract][Full Text] [Related]
23. Tumor angiogenesis and anti-angiogenic therapies.
Shahneh FZ; Baradaran B; Zamani F; Aghebati-Maleki L
Hum Antibodies; 2013; 22(1-2):15-9. PubMed ID: 24284305
[TBL] [Abstract][Full Text] [Related]
24. HOX transcript antisense RNA (HOTAIR) in cancer.
Qu X; Alsager S; Zhuo Y; Shan B
Cancer Lett; 2019 Jul; 454():90-97. PubMed ID: 30981759
[TBL] [Abstract][Full Text] [Related]
25. Targeting the long noncoding RNA MALAT1 blocks the pro-angiogenic effects of osteosarcoma and suppresses tumour growth.
Zhang ZC; Tang C; Dong Y; Zhang J; Yuan T; Tao SC; Li XL
Int J Biol Sci; 2017; 13(11):1398-1408. PubMed ID: 29209144
[TBL] [Abstract][Full Text] [Related]
26. A Novel Human Long Noncoding RNA SCDAL Promotes Angiogenesis through SNF5-Mediated GDF6 Expression.
Wu R; Hu W; Chen H; Wang Y; Li Q; Xiao C; Fan L; Zhong Z; Chen X; Lv K; Zhong S; Shi Y; Chen J; Zhu W; Zhang J; Hu X; Wang J
Adv Sci (Weinh); 2021 Sep; 8(18):e2004629. PubMed ID: 34319658
[TBL] [Abstract][Full Text] [Related]
27. Knocking Down Long Noncoding RNAs Using Antisense Oligonucleotide Gapmers.
Maruyama R; Yokota T
Methods Mol Biol; 2020; 2176():49-56. PubMed ID: 32865781
[TBL] [Abstract][Full Text] [Related]
28. LncRNAs as tumor cell intrinsic factors that affect cancer immunotherapy.
Egranov SD; Hu Q; Lin C; Yang L
RNA Biol; 2020 Nov; 17(11):1625-1627. PubMed ID: 32449433
[TBL] [Abstract][Full Text] [Related]
29. LINC00173.v1 promotes angiogenesis and progression of lung squamous cell carcinoma by sponging miR-511-5p to regulate VEGFA expression.
Chen J; Liu A; Wang Z; Wang B; Chai X; Lu W; Cao T; Li R; Wu M; Lu Z; Pang W; Xiao L; Chen X; Zheng Y; Chen Q; Zeng J; Li J; Zhang X; Ren D; Huang Y
Mol Cancer; 2020 May; 19(1):98. PubMed ID: 32473645
[TBL] [Abstract][Full Text] [Related]
30. Roles of long noncoding RNAs in colorectal cancer metastasis.
Li H; Ma SQ; Huang J; Chen XP; Zhou HH
Oncotarget; 2017 Jun; 8(24):39859-39876. PubMed ID: 28418892
[TBL] [Abstract][Full Text] [Related]
31. Angiogenesis regulation by microRNAs and long non-coding RNAs in human breast cancer.
Chong ZX; Yeap SK; Ho WY
Pathol Res Pract; 2021 Mar; 219():153326. PubMed ID: 33601152
[TBL] [Abstract][Full Text] [Related]
32. Reassessing vascular endothelial growth factor (VEGF) in anti-angiogenic cancer therapy.
Elebiyo TC; Rotimi D; Evbuomwan IO; Maimako RF; Iyobhebhe M; Ojo OA; Oluba OM; Adeyemi OS
Cancer Treat Res Commun; 2022; 32():100620. PubMed ID: 35964475
[TBL] [Abstract][Full Text] [Related]
33. Epitranscriptomic Signatures in lncRNAs and Their Possible Roles in Cancer.
Dinescu S; Ignat S; Lazar AD; Constantin C; Neagu M; Costache M
Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30654440
[TBL] [Abstract][Full Text] [Related]
34. Genetic lineage tracing reveals poor angiogenic potential of cardiac endothelial cells.
Kocijan T; Rehman M; Colliva A; Groppa E; Leban M; Vodret S; Volf N; Zucca G; Cappelletto A; Piperno GM; Zentilin L; Giacca M; Benvenuti F; Zhou B; Adams RH; Zacchigna S
Cardiovasc Res; 2021 Jan; 117(1):256-270. PubMed ID: 31999325
[TBL] [Abstract][Full Text] [Related]
35. The landscape of long non-coding RNAs in tumor stroma.
Uddin MN; Wang X
Life Sci; 2021 Jan; 264():118725. PubMed ID: 33166593
[TBL] [Abstract][Full Text] [Related]
36. κ Opioid receptor ligands regulate angiogenesis in development and in tumours.
Yamamizu K; Hamada Y; Narita M
Br J Pharmacol; 2015 Jan; 172(2):268-76. PubMed ID: 24417697
[TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA in prostate, bladder, and kidney cancer.
Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
[TBL] [Abstract][Full Text] [Related]
38. Mitochondria as targets in angiogenesis inhibition.
Park D; Dilda PJ
Mol Aspects Med; 2010 Feb; 31(1):113-31. PubMed ID: 19995570
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic Potential of the Serum lncRNAs HOTAIR, BRM and ICR for Hepatocellular Carcinoma.
Lou ZH; Xu KY; Qiao L; Su XQ; Ou-Yang Y; Miao LB; Liu F; Wang Y; Fu A; Ren XH; Huang JS; Li ZY; Bao JF
Front Biosci (Landmark Ed); 2022 Sep; 27(9):264. PubMed ID: 36224021
[TBL] [Abstract][Full Text] [Related]
40. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
Shinkaruk S; Bayle M; Laïn G; Déléris G
Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
